{
  "title": "Paper_803",
  "abstract": "Pharmacogenomics Pharmacogenomics 3074 pgs Pharmacogenomics 1462-2416 1744-8042 Taylor & Francis PMC11492661 PMC11492661.1 11492661 11492661 39347581 10.1080/14622416.2024.2403969 2403969 1 Version of Record Review Article Systematic Review A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level https://orcid.org/0009-0002-6420-7070 A. Zairol Azwan Farah Aida  a Teo Yi Ying  a https://orcid.org/0000-0002-7330-7148 Mohd Tahir Nor Asyikin *  a https://orcid.org/0000-0001-6243-6975 Saffian Shamin Mohd  a https://orcid.org/0000-0002-0592-0645 Makmor-Bakry Mohd  a  b https://orcid.org/0000-0003-1459-1844 Mohamed Said Mohd Shahrir  c a Centre for Quality Management of Medicines Faculty of Pharmacy Universiti Kebangsaan Malaysia Jalan Raja Muda Abdul Aziz 50300 Kuala Lumpur Malaysia b Faculty of Pharmacy Universitas Airlangga PQMM+9Q6 Gedung Nanizar Zaman Joenoes Kampus C UNAIR Jl. Mulyorejo, Mulyorejo Surabaya East Java 60115 Indonesia c Department of Medicine Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia Jalan Yaacob Latiff 56000 Kuala Lumpur Malaysia * 60392897367 syikin.tahir@ukm.edu.my 30 9 2024 2024 25 10-11 473183 479 494 30 09 2025 30 09 2025 22 10 2024 30 09 2025 Aptara 13 9 2024 30 9 2024 26 6 2024 10 9 2024 © 2024 Informa UK Limited, trading as Taylor & Francis Group 2024 Aim: Methods: Results: Conclusion: ABCG2 SLC2A9 SLC17A1 SLC22A12 SLC22A13 PDZK1 AOX1 GREM2 GREM2 Article highlights SNPs identified in ABCG2 SLC2A9 SLC17A1 SLC22A12 SLC22A13 AOX1 GREM2 PDZK1 Age, body mass index, ethnicity, sex, creatinine clearance and baseline urate levels are potential confounding variables that could contribute to the variability in oxypurinol clearance and allopurinol metabolism observed across different studies. Novel findings revealed ABCG2 Most European countries include Asian and European ancestries as subjects because these ethnicities have high minor allele frequencies of ABCG2 A significant association between allopurinol metabolism and the ABCG2 Genetic variations in uric acid transporters affect oxypurinol clearance, with renal excretion trends regulating serum uric acid levels, with a minimum oxypurinol concentration of approximately 104 μmol/l required to achieve target urate levels, increasing as renal function declines. SNPs in the GREM2 GREM2 While uric acid transporters and genetic polymorphisms associated with pharmacokinetics of allopurinol and oxypurinol, the effectiveness of allopurinol-based hyperuricemia treatment remains uncertain, as evidenced by the absence of therapeutic drug monitoring for these medications in clinical practice. Keywords: allopurinol clearance oxypurinol pharmacokinetics single nucleotide polymorphisms SNPs uric acid level Ministry of Higher Education, Malaysia 10.13039/501100003093 FRGS/1/2022/SKK16/UKM/03/1 The authors acknowledge this research was funded by the Ministry of Higher Education (MOHE), Malaysia through Fundamental Research Grant Scheme (FRGS) under the grant number FRGS/1/2022/SKK16/UKM/03/1. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access no pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes ",
  "metadata": {
    "Title of this paper": "A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level",
    "Journal it was published in:": "Pharmacogenomics",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492661/"
  }
}